United States · FDA National Drug Code directory
Lidocaine Hydrochloride and Dextrose
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0338-0411_9e9121a0-25dd-46ba-a2b7-6f71fc3ff9cd
- Product NDC
- 0338-0411
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Lidocaine Hydrochloride
- Labeler
- Baxter Healthcare Corporation
- Marketing category
- NDA
- Marketing start / end (source format)
- 19810422
- Source listing expiry
- 20271231
Source-listed ingredients
- LIDOCAINE HYDROCHLORIDE — 8 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 24 BAG in 1 CARTON (0338-0411-02) / 250 mL in 1 BAG · 0338-0411-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →